Skip to main content

Lisdexamfetamine Dimesylate Capsules Shortage

Last Updated: April 28, 2024
Status: Current

Products Affected - Description
    • Lisdexamfetamine dimesylate oral capsule, Alvogen, 10 mg, bottle, 100 count, NDC 47781-0562-01
    • Lisdexamfetamine dimesylate oral capsule, Alvogen, 20 mg, bottle, 100 count, NDC 47781-0563-01
    • Lisdexamfetamine dimesylate oral capsule, Alvogen, 30 mg, bottle, 100 count, NDC 47781-0564-01
    • Lisdexamfetamine dimesylate oral capsule, Alvogen, 40 mg, bottle, 100 count, NDC 47781-0565-01
    • Lisdexamfetamine dimesylate oral capsule, Alvogen, 50 mg, bottle, 100 count, NDC 47781-0566-01
    • Lisdexamfetamine dimesylate oral capsule, Alvogen, 60 mg, bottle, 100 count, NDC 47781-0567-01
    • Lisdexamfetamine dimesylate oral capsule, Alvogen, 70 mg, bottle, 100 count, NDC 47781-0568-01
    • Lisdexamfetamine dimesylate oral capsule, Amneal, 20 mg, bottle, 90 count, NDC 65162-0023-09
    • Lisdexamfetamine dimesylate oral capsule, Amneal, 30 mg, bottle, 90 count, NDC 65162-0024-09
    • Lisdexamfetamine dimesylate oral capsule, Amneal, 40 mg, bottle, 90 count, NDC 65162-0025-09
    • Lisdexamfetamine dimesylate oral capsule, Amneal, 50 mg, bottle, 90 count, NDC 65162-0026-09
    • Lisdexamfetamine dimesylate oral capsule, Amneal, 60 mg, bottle, 90 count, NDC 65162-0027-09
    • Lisdexamfetamine dimesylate oral capsule, Amneal, 70 mg, bottle, 90 count, NDC 65162-0028-09
    • Lisdexamfetamine dimesylate oral capsule, Hikma, 20 mg, bottle, 100 count, NDC 00054-0370-25
    • Lisdexamfetamine dimesylate oral capsule, Hikma, 30 mg, bottle, 100 count, NDC 00054-0371-25
    • Lisdexamfetamine dimesylate oral capsule, Hikma, 40 mg, bottle, 100 count, NDC 00054-0372-25
    • Lisdexamfetamine dimesylate oral capsule, Hikma, 50 mg, bottle, 100 count, NDC 00054-0373-25
    • Lisdexamfetamine dimesylate oral capsule, Hikma, 60 mg, bottle, 100 count, NDC 00054-0374-25
    • Lisdexamfetamine dimesylate oral capsule, Hikma, 70 mg, bottle, 100 count, NDC 00054-0375-25
    • Lisdexamfetamine dimesylate oral capsule, Lannett, 10 mg, bottle, 100 count, NDC 00527-4661-37
    • Lisdexamfetamine dimesylate oral capsule, Lannett, 20 mg, bottle, 100 count, NDC 00527-4662-37
    • Lisdexamfetamine dimesylate oral capsule, Lannett, 30 mg, bottle, 100 count, NDC 00527-4663-37
    • Lisdexamfetamine dimesylate oral capsule, Lannett, 40 mg, bottle, 100 count, NDC 00527-4664-37
    • Lisdexamfetamine dimesylate oral capsule, Lannett, 50 mg, bottle, 100 count, NDC 00527-4665-37
    • Lisdexamfetamine dimesylate oral capsule, Lannett, 60 mg, bottle, 100 count, NDC 00527-4666-37
    • Lisdexamfetamine dimesylate oral capsule, Lannett, 70 mg, bottle, 100 count, NDC 00527-4667-37
    • Lisdexamfetamine dimesylate oral capsule, Mylan (Viatris), 10 mg, bottle, 90 count, NDC 00378-6854-77
    • Lisdexamfetamine dimesylate oral capsule, Mylan (Viatris), 20 mg, bottle, 90 count, NDC 00378-6855-77
    • Lisdexamfetamine dimesylate oral capsule, Mylan (Viatris), 30 mg, bottle, 90 count, NDC 00378-6856-77
    • Lisdexamfetamine dimesylate oral capsule, Mylan (Viatris), 40 mg, bottle, 90 count, NDC 00378-6857-77
    • Lisdexamfetamine dimesylate oral capsule, Mylan (Viatris), 50 mg, bottle, 90 count, NDC 00378-6858-77
    • Lisdexamfetamine dimesylate oral capsule, Mylan (Viatris), 60 mg, bottle, 90 count, NDC 00378-6859-77
    • Lisdexamfetamine dimesylate oral capsule, Mylan (Viatris), 70 mg, bottle, 90 count, NDC 00378-6860-77
    • Lisdexamfetamine dimesylate oral capsule, Rhodes, 10 mg, bottle, 100 count, NDC 42858-0161-01
    • Lisdexamfetamine dimesylate oral capsule, Rhodes, 20 mg, bottle, 100 count, NDC 42858-0162-01
    • Lisdexamfetamine dimesylate oral capsule, Solco Healthcare US, 10 mg, bottle, 100 count, NDC 43547-0602-10
    • Lisdexamfetamine dimesylate oral capsule, Solco Healthcare US, 20 mg, bottle, 100 count, NDC 43547-0603-10
    • Lisdexamfetamine dimesylate oral capsule, Solco Healthcare US, 30 mg, bottle, 100 count, NDC 43547-0604-10
    • Lisdexamfetamine dimesylate oral capsule, Solco Healthcare US, 40 mg, bottle, 100 count, NDC 43547-0605-10
    • Lisdexamfetamine dimesylate oral capsule, Solco Healthcare US, 50 mg, bottle, 100 count, NDC 43547-0606-10
    • Lisdexamfetamine dimesylate oral capsule, Solco Healthcare US, 60 mg, bottle, 100 count, NDC 43547-0607-10
    • Lisdexamfetamine dimesylate oral capsule, Solco Healthcare US, 70 mg, bottle, 100 count, NDC 43547-0608-10
    • Lisdexamfetamine dimesylate oral capsule, Sun Pharma, 10 mg, bottle, 100 count, NDC 57664-0046-88
    • Lisdexamfetamine dimesylate oral capsule, Sun Pharma, 20 mg, bottle, 100 count, NDC 57664-0047-88
    • Lisdexamfetamine dimesylate oral capsule, Sun Pharma, 30 mg, bottle, 100 count, NDC 57664-0048-88
    • Lisdexamfetamine dimesylate oral capsule, Sun Pharma, 40 mg, bottle, 100 count, NDC 57664-0049-88
    • Lisdexamfetamine dimesylate oral capsule, Sun Pharma, 50 mg, bottle, 100 count, NDC 57664-0050-88
    • Lisdexamfetamine dimesylate oral capsule, Sun Pharma, 60 mg, bottle, 100 count, NDC 57664-0051-88
    • Lisdexamfetamine dimesylate oral capsule, Sun Pharma, 70 mg, bottle, 100 count, NDC 57664-0052-88
Reason for the Shortage
    • Alvogen has lisdexamfetamine capsules on shortage due to regulatory delays.
    • Amneal has lisdexamfetamine capsules on shortage due to an issue with the active ingredient.
    • Hikma has lisdexamfetamine capsules on shortage due to an issue with the active ingredient.
    • Lannett did not provide a reason for the shortage.
    • Mallinckrodt does not provide information on drug shortages.
    • Mylan has lisdexamfetamine capsules available.
    • Rhodes launched lisdexamfetamine 30 mg, 40 mg, 50 mg, 60 mg, and 70 mg capsules in March 2024. The 10 mg and 20 mg capsules have not been launched and the company cannot estimate a release date.
    • Solco has lisdexamfetamine capsules on shortage due to an issue with the active ingredient.
    • Sun Pharma has lisdexamfetamine capsules on shortage due to regulatory delays.
    • Takeda has Vyvanse available.
Available Products
    • Vyvanse oral capsule, Takeda, 10 mg, bottle, 100 count, NDC 59417-0101-10
    • Vyvanse oral capsule, Takeda, 20 mg, bottle, 100 count, NDC 59417-0102-10
    • Vyvanse oral capsule, Takeda, 30 mg, bottle, 100 count, NDC 59417-0103-10
    • Vyvanse oral capsule, Takeda, 40 mg, bottle, 100 count, NDC 59417-0104-10
    • Vyvanse oral capsule, Takeda, 50 mg, bottle, 100 count, NDC 59417-0105-10
    • Vyvanse oral capsule, Takeda, 60 mg, bottle, 100 count, NDC 59417-0106-10
    • Vyvanse oral capsule, Takeda, 70 mg, bottle, 100 count, NDC 59417-0107-10
    • Lisdexamfetamine dimesylate oral capsule, Rhodes, 30 mg, bottle, 100 count, NDC 42858-0163-01
    • Lisdexamfetamine dimesylate oral capsule, Rhodes, 40 mg, bottle, 100 count, NDC 42858-0164-01
    • Lisdexamfetamine dimesylate oral capsule, Rhodes, 50 mg, bottle, 100 count, NDC 42858-0165-01
    • Lisdexamfetamine dimesylate oral capsule, Rhodes, 60 mg, bottle, 100 count, NDC 42858-0166-01
    • Lisdexamfetamine dimesylate oral capsule, Rhodes, 70 mg, bottle, 100 count, NDC 42858-0167-01

Estimated Resupply Dates

    • Alvogen has lisdexamfetamine 10 mg and 70 mg capsules in limited supply. The 40 mg and 60 mg capsules are on back order and the company estimates a resupply in late-April 2024. All other presentations are on back order and the company cannot estimate a release date.
    • Amneal has lisdexamfetamine capsules on back order and the company cannot estimate a release date.
    • Hikma has lisdexamfetamine capsules on allocation.
    • Lannett has lisdexamfetamine 10 mg capsules on allocation. All other presentations are on back order and the company cannot estimate a release date.
    • Mylan has lisdexamfetamine capsules available in limited supply.
    • Solco has lisdexamfetamine capsules on allocation.
    • Sun Pharma has all presentations on back order and the company estimates additional product will be available in May to June 2024.

Alternative Agents & Management

    • Vyvanse chewable tablets are not affected by this shortage.

Updated

Updated April 28, 2024 by Elyse MacDonald, PharmD, MS, BCPS. Created June 19, 2023 by Leslie Jensen, PharmD, Drug Information Specialist. © 2024, Drug Information Service, University of Utah, Salt Lake City, UT.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer